Abstract
The gene encoding mouse transcription factor Oct-1 contains two exons, 1U and 1L, at the 5′ end. Oct-1 mRNA from all tissues contains exon 1U, whereas exon 1L is found only in Oct-1 mRNA from mouse and human lymphoid cells. Upstream of 1U and 1L exons, the respective specific promoters, U and L, are located at a considerable distance from each other (67 kb in the mouse otf-1 locus). These regions differ in their structure. The region upstream from exon 1U contains numerous Sp1 sites, whereas the region upstream from exon 1L contains homeospecific NTAATNN sites and two octa sites ATGCAAAT recognized by transcription factors Oct-1, Oct-2, and by other POU domain-containing proteins. The octa and homeospecific sites promote autoregulation of the oct-1 gene. Transfection of U and L promoter fragments within pGL3 Basic plasmid or pGL3 Enhancer vector into lymphoid NS/0 myeloma cells or 10(1) fibroblasts showed that the L promoter activity was many times higher in the myeloma cells than in fibroblasts. Between the sites of translation and transcription initiation from the L promoter, a nucleotide sequence was identified whose elimination resulted in a significantly higher efficiency of transcription initiation from this promoter. Thus, the oct-1 gene contains at least two alternative promoters: the U promoter apparently provides for the constitutive synthesis of Oct-1 protein, whereas the L promoter manifests tissue specificity, contains octa sites, and appears to be self-regulated.
Similar content being viewed by others
REFERENCES
Herr W., Sturm R.A., Clerc R.G., Corcoran L.M., Baltimore D. 1988. The POU domain: A large conserved region in the mammalian pit-1, oct-1, oct-2, and C. elegans unc-86 gene products. Genes Dev. 2, 1513–1516.
Falkner F.C., Zachau H.G. 1984. Correct transcription of immunoglobulin k-gene requires an upstream fragment containing conserved sequence elements. Nature. 310, 71–74.
Herr W., Cleary M. 1995. The POU domain: Versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. Genes Dev. 9, 1679–1693.
Stepchenko A.G., Polyanovsky O.L. Interaction of Oct proteins with DNA. Mol. Biol. 30, 503–513.
Phillips K., Luisi B. 2000. The virtuoso versatility: POU proteins that flex to fit. J. Mol. Biol. 302, 1023–1039.
Deyev I.E., Polanovsky O.L. 2004. oct genes and Oct proteins. Mol. Biol. 38, 48–55.
Sytina E.V., Pankratova E.V. 2003. Transcription factor Oct-1: Plasticity and multifunctionality. Mol. Biol. 37, 775–767.
Kim M.K., Lessoon-Wood L.A., Weintraub B.D., Chung J.H. 1996. A soluble transcription factor, Oct-1, is also found in the insoluble nuclear matrix and possesses silencing activity in its alanine-rich domain. Mol. Cell Biol. 16, 4366–4377.
Veenstra G.J.C., Petrson-Maduro J., Mathu M.T., van der Vliet P.C., Destree O.H.J. 1998. Non-cell autonomus induction of apoptosis and loss of posterior structures by activation domain-specific interactions of Oct-1 in the Xenopus embryo. Cell Death Differ. 5, 774–784.
Veenstra G.J.C., van der Vliet P.C., Destree O.H.J. 1997. POU domain transcription factors in embryonic development. Mol. Biol. Repts. 24, 139–155.
Koyasu S., Hussey R.E., Clayton L.K., Lerne A. 1994. Targeted disruption within the CD3 zeta/phi/Oct-1 locus in mouse. EMBO J. 13, 784–797.
Pankratova E.V., Deyev I.E., Polanovsky O.L. 2001. Tissue-specific splicing of the 5′ exons of the transcription factor Oct-1 gene. Mol. Biol. 35, 34–41.
Pankratova E.V., Deyev I.E., Zhenilo S.V., Polanovsky O.L. 2001. Tissue-specific isoforms of the ubiquitous transcription factor Oct-1. Mol. Genet. Genomics. 266, 239–245.
Deyev I.E., Zhenilo S.V., Polanovsky O.L. 2003. Spliced oct-1 mRNA isoforms with untranslated exons and a partly deleted region coding for the POU-specific domain. Mol. Biol. 37, 139–146.
Luchina N.N., Krivega I.V., Pankratova E.V. 2003. Human Oct-1 isoform has tissue-specific expression pattern similar to Oct-1. Immunol. Lett. 85, 237–241.
Manley J.L. 1984. In: Transcription and Translation. A Practical Approach. Eds Hames B.D., Higgins S.G. Oxford: IRL Press, 89–110.
Rubtsov P.M. 2000. Alternative promoters and RNA processing in expression of the eukaryotic genome. Mol. Biol. 34, 626–634.
Landry J.-R., Mager D.L., Wilhelm B.T. 2003. Complex controls: The role of alternative promoters in mammalian genomes. Trends Genet. 19, 640–648.
Struhl G., Struhl K., Macdonald P.M. 1989. The gradient morphogen bicoid is a concentration-dependent transcriptional activator. Cell. 57, 1259–1273.
Schubart K., Massa S., Schubart D., Corcoran L.M., Rolink A.G., Matthias P. 2001. B cell development and immunoglobulin gene transcription in the absence of Oct-1 and OBF-1. Nature Immunol. 2, 784–797.
Veenstra G.J.C. 1995. Dynamic and difftrential oct-1 expression during early Xenopus embryogenesis: Persistence of Oct-1 protein following down-regulation of the RNA. Mech. Devel. 50, 103–117.
He X., Treacy M.N., Simmons D.M., Ingraham H.A., Swanson L.W., Rosenfeld M.G. 1989. Expression of a large family of POU domain regulatory genes in mammalian brain development. Nature. 340, 35–42.
Zhenilo S.V., Deyev I.E., Serov S.M., Polanovsky O.L. 2003. Regulation of human oct-1 gene expression with the involvement of two promoters. Genetika. 39, 280–285.
Zhenilo S., Deyev I., Serov S., Polanovsky O.L. 2003. Regulation of oct-1 gene is different in lymphoid and non-lymphoid cells. Biochimie. 85, 715–718.
Faisst S., Meyer S. 1992. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20, 3–26.
Ryan A.K., Rosenfeld M.G. 1997. POU domain family values: Flexibility partnership, and developmental codes. Genes Dev. 11, 1207–1225.
Luo J., Roeder R.G. 1995. Cloning, functional characterization, and mechanism of action of the B-cell specific transcriptional co-activator OCA-B. Mol. Cell Biol. 15, 4115–4124.
Gstaiger M., Knoepfel L., Georgiev O., Schaffner W., Hovens C.M. 1995. A B-cell coactivator of octamer-binding transcription factors. Nature. 373, 360–362.
Strubin M., Newell J.W., Matthias P. 1995. OBF-1 a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell. 80, 497–506.
Zheng L., Roeder R.G., Luo Y. 2003. S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component. Cell. 114, 255–266.
Chominski P., Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium-phenol-chloroform extraction. Anal. Biochem. 162, 156–159.
Stepchenko A.G. 1992. The nucleotide sequence of mouse Oct-1 cDNA. Nucleic Acids Res. 20, 1419.
Das G., Herr W. 1993. Enhanced activation of the human histone H2B promoter by an Oct-1 variant generated by alternative splicing. J. Biol. Chem. 288, 25026–25032.
Suzuki N., Peter W., Ciesiolka T., Gruss P., Scholer H.R. 1993. Mouse Oct-1 contains a composite homeodomain of human Oct-1 and Oct-2. Nucleic Acids Res. 21, 245–252.
Wang Y., Newton D.C., Robb G.B., Kau C.-L., Miller T.L., Cheung A.H., Hall A.V., van Damme S., Wilcox J.N., Marsden P.H. 1999. RNA diversity has profound effects on the translation of neuronal oxide synhthase. Proc. Natl. Acad. Sci. USA. 96, 12150–12155.
Orladnova O., Syagailo Y.V., Mossner R., Riederer P., Lesh K.P. 1998. Regulation of Pax-6 gene transcription: Alternative promoter usage in human brain. Brain Res. Mol. Res. 60, 177–192.
Author information
Authors and Affiliations
Additional information
__________
Translated from Molekulyarnaya Biologiya, Vol. 39, No. 6, 2005, pp. 952–959.
Original Russian Text Copyright © 2005 by Pankratova, Sytina, Stepchenko, Manuylova, Polanovsky.
Rights and permissions
About this article
Cite this article
Pankratova, E.V., Sytina, E.V., Stepchenko, A.G. et al. Alternative Promoters and Tissue-Specific Regulation of Mouse oct-1 Gene Transcription. Mol Biol 39, 833–839 (2005). https://doi.org/10.1007/s11008-005-0102-0
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11008-005-0102-0